Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 7, 2008; 14(21): 3313-3327
Published online Jun 7, 2008. doi: 10.3748/wjg.14.3313
Published online Jun 7, 2008. doi: 10.3748/wjg.14.3313
First author | No. of patients | Study design and duration of follow up | UDCA effects on | ||
Pruritus | Histology | Survival | |||
Poupon[191] | 146 | 2 yr | Improved | Improved | No effect |
Heathcote[192] | 222 | 2 yr | No effect | Improved | No effect |
Lindor[193] | 180 | Mean follow up: 2 yr | No effect | No effect | No effect |
Combes[194] | 151 | 2 yr | Improved | Improved (early stages) | No effect |
Eriksson[195] | 116 | 2 yr + 2 yr as open trial (UDCA) | No effect | No effect | No effect |
Pares[196] | 192 | Mean follow up: 3.4 yr | Improved | Improved | No effect |
Papatheodoritis[197] | 86 | Mean follow up 7.3 yr for UDCA 8.1 yr for controls | Not evaluated | No effect | No effect |
- Citation: Crosignani A, Battezzati PM, Invernizzi P, Selmi C, Prina E, Podda M. Clinical features and management of primary biliary cirrhosis. World J Gastroenterol 2008; 14(21): 3313-3327
- URL: https://www.wjgnet.com/1007-9327/full/v14/i21/3313.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3313